Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome ; day:30 ; month:6 ; year:2016 ; pages:1-5
Zeitschrift für Kinderheilkunde ; (30.6.2016), 1-5
- Urheber
-
Grenda, Ryszard
- Beteiligte Personen und Organisationen
-
Jarmużek, Wioletta
Rubik, Jacek
Piątosa, Barbara
Prokurat, Sylwester
SpringerLink (Online service)
- DOI
-
10.1007/s00431-016-2747-1
- URN
-
urn:nbn:de:1111-2016070233824
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grenda, Ryszard
- Jarmużek, Wioletta
- Rubik, Jacek
- Piątosa, Barbara
- Prokurat, Sylwester
- SpringerLink (Online service)
Ähnliche Objekte (12)
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances